Vertex Pharmaceuticals · Capital Lease Obligations

Latest reported$1.95Bperiod endingDec 31, 2025

VRTX FY Capital Lease Obligations ($0.00 → $1.95B)

Annual capital lease obligations

High-resolution chart · PNG

VRTX capital lease obligations history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Vertex Pharmaceuticals Capital Lease Obligations — Annual fiscal periods (USD)
Period ending	Capital Lease Obligations (USD)
Dec 31, 2025	1,953,200,000
Dec 31, 2024	1,657,200,000
Dec 31, 2023	808,400,000
Dec 31, 2022	899,700,000
Dec 31, 2021	967,400,000
Dec 31, 2020	931,900,000
Dec 31, 2019	661,662,000
Dec 31, 2018	586,821,000
Dec 31, 2017	606,433,000
Dec 31, 2016	540,761,000
Dec 31, 2015	531,079,000
Dec 31, 2014	530,172,000
Dec 31, 2013	506,584,000
Dec 31, 2012	296,908,000
Dec 31, 2011	55,950,000
Dec 31, 2010	0
Dec 31, 2009	32,071,000
Dec 31, 2008	0
Dec 31, 2007	0
Dec 31, 2006	0
Dec 31, 2005	0
Dec 31, 2004	0
Dec 31, 2003	25,728,000
Dec 31, 2002	10,944,000
Dec 31, 2001	8,026,000
Dec 31, 2000	-18,916,000
Dec 31, 1999	0
Dec 31, 1998	0
Dec 31, 1997	0
Dec 31, 1996	0
Dec 31, 1995	0
Dec 31, 1994	0
Dec 31, 1993	0
Dec 31, 1992	0
Dec 31, 1991	0
Dec 31, 1990	0